| Common Name | FPA-150, FPA150 |
|---|---|
| Synonyms | B7-H4， B7h.5， B7H4， B7S1， B7X， PRO1291， VCTN1 |
| Applications | ELISA, Flow Cyt |
| Recommended Dilutions | ELISA 1:5000-10000, Flow Cyt 1:100 |
| Buffer | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions. |
| Formulation & Reconstitution | Powder |
| Host Species | Homo sapiens |
| IgG type | IgG1 |
| Reactivity | Human |
| Storage | |
| Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized proteins are shipped at ambient temperature. |
| Guarantee | 12 months from date of dispatch |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
Anti-B7-H4(alsevalimab biosimilar) mAb
Price: 50μg $80.00 ; 100 μg $160.00
Product Data
Images
Figure 1. ELISA plate pre-coated by 1 μg/ml (100 μl/well) Human B7-H4, hFc-His tagged protein (PME100053) can bind Anti-B7-H4 Neutralizing antibody (BME100078) in a linear range of 3.2-80 ng/ml.
Figure 2. Flow cytometry analysis with 1 μg/mL Anti-B7-H4 (alsevalimab) mAb (BME100078) on Expi293 cells transfected with Human B7-H4 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).